144989-61-7

Basic information

• Product Name: Carbamic acid, [(1R,2R)-2-hydroxycyclopentyl]-, phenylmethyl ester, rel-
• CAS NO: 144989-61-7
• Molecular Formula: C13H17NO3
• Molecular Weight: 235.283
• Mol File: 144989-61-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1R,2R)-2-hydroxycyclopentyl]-, phenylmethyl ester, rel-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R,2R)-2-hydroxycyclopentyl]-, phenylmethyl ester, rel-(144989-61-7)
• EPA Substance Registry System: Carbamic acid, [(1R,2R)-2-hydroxycyclopentyl]-, phenylmethyl ester, rel-(144989-61-7)

Safety Data

• Hazardous Substances Data: 144989-61-7(Hazardous Substances Data)

Upstream product

• 31775-67-4 (±)-trans-2-aminocyclopentanol hydrochloride 
• 501-53-1 benzyl chloroformate 
• 285-67-6 Cyclopentene oxide 
• 28435-62-3 (+/-)-trans-2-bromocyclopentanol 
• 285-67-6 (1S,5R)-6-Oxa-bicyclo[3.1.0]hexane 
• 33092-86-3 trans-2-aminocyclopentanol 

Downstream Products

• 1306310-32-6 (trans)-2-methoxycyclopentan-1-amine 
• 144989-62-8 (3aR,6aS)-2-Ethoxy-4,5,6,6a-tetrahydro-3aH-cyclopentaoxazole 
• 198422-71-8 benzyl (1S,2S)-trans-N-(2-hydroxycyclopentyl)carbamate 
• 114364-42-0 cis-hexahydrocyclopentaoxazol-2-one 

Relevant articles and documents

FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF

The present invention relates to an FGFR4 inhibitor having a structure represented by formula (I), preparation method therefor, and applications thereof. A series of compounds represented by formula (I) in the present invention have a very-strong inhibiti

A General Route to the Synthesis of N-Protected 1-Substituted and 1,2-Disubstituted Taurines

N-Benzyloxycarbonyl protected α-substituted and αβ- disubstituted taurines were synthesized from olefins and epoxides via N-benzyloxycarbonylamino alcohol thioacetates as key intermediates. They are important sulfur analogues of naturally occurring amino acids and building blocks for the synthesis of α-substituted and α,β- disubstituted β-sulfonopeptides.

An Enantiospecific Synthesis of Allosamizoline

An enantiospecific synthesis of allosamizoline 4, the aglycone of the chitinase inhibitor allosamidin 3, has been achieved, starting from readily available glucosamine.The key step in the synthesis involves the cyclisation of a carbon-centred radical onto